CASE STUDIES

STUDY 1:

Precision Medicine Company

The challenge: A precision medicine company was in the process of commercializing a highly predictive biodiagnostic test to determine the effectiveness of costly psoriasis treatment. Administered before treatment, the test will help practitioners prescribe the best treatment for Individuals.

The process: RxTalents consulted on product strategy, value proposition, available and target markets, market access, and pricing. RxTalents assisted the company in establishing the test’s cost-effectiveness, thoroughly assessing the clinical impact of the test, and coordinating strategic alliances to strengthen the company’s position.

The result: The company was able to bring its test to market based on a strong foundation and poised for growth. Most importantly, psoriasis individuals will experience better clinical outcomes based on test results.

STUDY 3:

Large Employer

The challenge: A large employer was concerned that medication expenditures were 130% of benchmarks.

The process: After assessing the data, RxTalents advised the employer on opportunities to reduce their drug spending, including two treatments costing in excess of $3.1 million.

The result: The employer recognized a 15% reduction in expenditures—nearly $1.5 million annually

STUDY 5:

Medicare Individual

The challenge:  A Medicare individual has been prescribed a medication that carried an out-of-pocket expense of $650 after insurance (which covered just $50 of the cost). The individual inquired about alternatives and discovered no generic was available.

The process:  RxTalents advised the individual to ask the prescribing physician to prescribe an alternative (and similar) product that has a generic available.

The result:  The physician prescribed the alternative, and the individual incurred just $90 out-of-pocket, resulting in  savings of more than $1,000 annually.

STUDY 2:

Pharmaceutical Manufacturer

The challenge: A pharmaceutical manufacturer was striving to commercialize an innovative wound care product for chronic wounds that were typically difficult to treat. The product has been proven to successfully close wounds that have been unhealed for months, even years.

The process: RxTalents consulted on the most marketable product strategy and value proposition. We assessed the addressable market, the served market, and the target market, and advised the company on market access and pricing issues. RxTalents also provided insight into challenges surrounding regulatory affairs and product marketing.

The result: The client established distribution and individual access programs (which delivered close to 100% insurance coverage of the product); assessed cost-effectiveness and clinical impact, and coordinated strategic alliances

STUDY 4:

Large Employer

The challenge: This large employer was experiencing pharmaceutical expenditures of 200% of benchmarks.

The process: RxTalents conducted a thorough assessment of the company’s data and identified cost-saving opportunities that could reduce their drug spending by 50% – nearly $1 million annually.

The result: The company significantly reduced the its drug spending, improved utilization of generic medications, negotiated better pricing, and hired a dedicated Pharmacy Benefit Manager.

STUDY 1:

Precision Medicine Company

The challenge: A precision medicine company was in the process of commercializing a highly predictive biodiagnostic test to determine the effectiveness of costly psoriasis treatment. Administered before treatment, the test will help practitioners prescribe the best treatment for patients.

The process: RxTalents consulted on product strategy, value proposition, available and target markets, market access, and pricing. RxTalents assisted the company in establishing the test’s cost-effectiveness, thoroughly assessing the clinical impact of the test, and coordinating strategic alliances to strengthen the company’s position.

The result: The company was able to bring their test to market based on a strong foundation and poised for growth. Most importantly, psoriasis patients will experience better clinical outcomes based on test results.

STUDY 2:

Pharmaceutical Manufacturer

The challenge: A pharmaceutical manufacturer was striving to commercialize an innovative wound care product for chronic wounds that were typically difficult to treat. The product has been proven to successfully close wounds that have been unhealed for months, even years.

The process: RxTalents consulted on the most marketable product strategy and value proposition. We assessed the addressable market, the served market, and the target market, and advised the company on market access and pricing issues. RxTalents also provided insight into challenges surrounding regulatory affairs and product marketing.

The result: The client established distribution and patient access programs (which delivered close to 100% insurance coverage of the product); assessed cost-effectiveness and clinical impact, and coordinated strategic alliances

STUDY 3:

Large Employer

The challenge: A large employer was concerned that medication expenditures were 130% of benchmarks.

The process: After assessing the data, RxTalents advised the employer on opportunities to reduce their drug spend, including two treatments costing in excess of $3.1 million.

The result: The employer recognized a 15% reduction in expenditures—nearly $1.5 million annually.

STUDY 4:

Large Employer

The challenge: A pharmaceutical manufacturer was striving to commercialize an innovative wound care product for chronic wounds that were typically difficult to treat. The product has been proven to successfully close wounds that have been unhealed for months, even years.

The process: RxTalents consulted on the most marketable product strategy and value proposition. We assessed the addressable market, the served market, and the target market, and advised the company on market access and pricing issues. RxTalents also provided insight into challenges surrounding regulatory affairs and product marketing.

The result: The client established distribution and patient access programs (which delivered close to 100% insurance coverage of the product); assessed cost-effectiveness and clinical impact, and coordinated strategic alliances

The result: The company was able to bring their test to market based on a strong foundation and poised for growth. Most importantly, psoriasis patients will experience better clinical outcomes based on test results.

STUDY 5:

Medicare Patient

The challenge:  A Medicare patient has been prescribed a medication that carried an out-of-pocket expense of $650 after insurance (which covered just $50 of cost). The patient inquired about alternatives and discovered no generic was available.

The process:  RxTalents advised the patient to ask the prescribing physician to prescribe an alternative (and similar) product that has a generic available.

The result:  The physician prescribed the alternative, and the patient incurred just $90 out-of-pocket, resulting in a savings of more than $1,000 annually.